Anthogyr adds a high-quality, attractively priced European brand to the group’s portfolio, supporting its strategy to penetrate the attractive non-premium implant segment. With a history of almost 30 years in implantology, Anthogyr is a well-established company that develops, manufactures and sells high-quality, innovative implant and CAD/CAM solutions. Its comprehensive portfolio addresses the upper value implant segment and includes fully and apically tapered designs, as well as parallel-walled tissue and bone level implants. The company has a strong clinical network of key opinion leaders in its home market, where it is the largest supplier of non-premium implant solutions. The partnership between the two companies dates back to early 2016, when Straumann acquired a 30 per cent stake in Anthogyr and took over its business in China.

“Our companies are a good cultural fit, and our partnership over the past three years has been very successful. Anthogyr provided us with timely footholds in the non-premium implant segments in China and Russia, where we have been able to generate strong growth with the brand. Our goal is to drive its international expansion together with Neodent, MEDENTiKA and our other brands, offering customers and their patients high-quality implant solutions with a broader range of price options than other companies can offer,” commented the CEO of the Straumann Group, Marco Gadola.

Éric Genève, President and CEO of Anthogyr, added: “Straumann provides us with the global platform and resources we need to expand internationally. We have already expanded our state-of-the-art manufacturing capacity in preparation for future growth and will benefit from the group’s global sales, marketing and distribution capabilities. We are immensely proud of our union with the world’s leading implant company and are convinced that it will add value for our staff, customers and patients.”

Tags: